Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma Academic Article uri icon

Overview

MeSH Major

  • Databases, Factual
  • Melanoma
  • Neoplasm Staging
  • Skin Neoplasms

abstract

  • Estimates of stage-specific survival were altered substantially by the changes made in the 2002 AJCC staging system for melanoma, particularly for Stage II. Stage subgroups that were added in the 2002 system resulted in a large diversity of risk within Stage III. This must be taken into account to stratify patients properly for clinical trials. The increased complexity of the 2002 system did not improve its predictive ability over the simpler 1997 system, highlighting the importance of developing individualized risk-prediction models.

publication date

  • January 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21594

PubMed ID

  • 16331596

Additional Document Info

start page

  • 163

end page

  • 71

volume

  • 106

number

  • 1